Cadmium interferes with the antiproliferative effect of fulvestrant in endocrine therapy-resistant estrogen receptor α-positive breast cancer cells

Toxicology Letters 2026

View at publisher

Authors: Koki Kanameda, Masayo Hirao-Suzuki, Shuso Takeda

DOI: 10.1016/j.toxlet.2026.111829

Cited by: 0

References: 32

Fields of Study & Subjects

Estrogen and related hormone effects Effects and risks of endocrine disrupting chemicals Advanced Breast Cancer Therapies

References 32